19-54219209-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006864.4(LILRB3):c.1346C>T(p.Ser449Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000205 in 1,602,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006864.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LILRB3 | NM_006864.4 | c.1346C>T | p.Ser449Leu | missense_variant | 8/13 | ENST00000445347.2 | NP_006855.3 | |
LOC124904768 | XR_007067339.1 | n.315G>A | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LILRB3 | ENST00000445347.2 | c.1346C>T | p.Ser449Leu | missense_variant | 8/13 | 2 | NM_006864.4 | ENSP00000388199 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 59AN: 152092Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000195 AC: 45AN: 230762Hom.: 0 AF XY: 0.000175 AC XY: 22AN XY: 125606
GnomAD4 exome AF: 0.000185 AC: 268AN: 1450380Hom.: 0 Cov.: 37 AF XY: 0.000176 AC XY: 127AN XY: 721846
GnomAD4 genome AF: 0.000394 AC: 60AN: 152212Hom.: 0 Cov.: 31 AF XY: 0.000349 AC XY: 26AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.1346C>T (p.S449L) alteration is located in exon 8 (coding exon 8) of the LILRB3 gene. This alteration results from a C to T substitution at nucleotide position 1346, causing the serine (S) at amino acid position 449 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at